Immunotherapy is a great advance in cancer treatment but up to a quarter of lung cancer patients are not eligible for this therapy. Autoimmune disorders have something to do with the risks.
Immunotherapy is a great advance in cancer treatment but up to a quarter of lung cancer patients are not eligible for this therapy. Autoimmune disorders have something to do with the risks.
Share this Article
Comment on this Article
Recommended
Please to comment